Literature DB >> 2292036

Evidence for the presence of angiotensin II-type 1 receptors in brain.

J K Wamsley1, W F Herblin, M E Alburges, M Hunt.   

Abstract

Angiotensin II receptor subtypes have been localized in brain by using a novel nonpeptide AII-type 1 receptor antagonist to compete with [125I]AII binding in an autoradiographic study. These data contrast with results obtained using the AII-type 2 antagonist PD123177. Both receptor subtypes appear to exist in the brain, but the type 1 receptor predominates in the small regions of brain where AII binding is highly concentrated. DUP 753 may have a central action involved in its unique antihypertensive effect.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2292036     DOI: 10.1016/0361-9230(90)90226-p

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  3 in total

1.  Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat.

Authors:  P Picard; L Chrétien; R Couture
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

2.  Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain.

Authors:  C Sumners; W Tang; B Zelezna; M K Raizada
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

3.  Access of peripherally administered DuP 753 to rat brain angiotensin II receptors.

Authors:  K F Song; J L Zhuo; F A Mendelsohn
Journal:  Br J Pharmacol       Date:  1991-12       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.